The remote patient monitoring (RPM) devices market was valued at USD 21.3 billion in 2024 and is expected to grow at a CAGR of 18.9% from 2025 to 2030. The increasing prevalence of chronic diseases and the rising demand for at-home healthcare solutions are driving the growth of this market. RPM devices are used to monitor patients’ vital signs and provide healthcare providers with real-time data, reducing the need for hospital visits and improving patient outcomes.
Product Insights
Vital sign monitoring devices held the largest market share in 2024, accounting for 58.1% of the total revenue, as these devices are commonly used to track blood pressure, heart rate, and oxygen levels in patients with chronic conditions. Devices used for chronic disease management are also expected to grow rapidly, particularly for managing diabetes and cardiovascular diseases.
Regional Insights
North America dominates the RPM devices market with a 42.5% share in 2024, owing to the region’s advanced healthcare infrastructure and high adoption of telehealth technologies. The Asia Pacific region is expected to see the fastest growth, with a CAGR of 20.6%, driven by increasing healthcare investments and the growing need for remote care solutions.